A Study of BV-araU in the Treatment of Varicella-Zoster Viral Disease (VZV) in HIV-Infected Children Who Have Not Had Success With or Who Cannot Take Other Treatments for VZV

Inclusion Criteria Patients must have: * HIV infection. * Cutaneous, visceral, or ocular varicella-zoster viral infection. * Refractory or intolerant to acyclovir or foscarnet therapy. * Consent of parent or guardian. Exclusion Criteria Co-existing Condition: Patients with the following symptoms or conditions are excluded: * Inability to take oral capsules or tolerate liquids. Concurrent Medication: Excluded: * 5-flucytosine, 5-fluorouracil, high-dose prednisone, or probenecid. Patients with the following prior condition are excluded: History of immediate hypersensitivity to nucleoside analogues. Prior Medication: Excluded: * 5-flucytosine, 5-fluorouracil, high-dose prednisone, or probenecid within 4 weeks prior to study entry. Required: * Prior acyclovir or foscarnet.